Literature DB >> 21274696

[Treatment of Alzheimer's disease according to the S3 guidelines on dementia. Choline esterase inhibitors for all and for ever?].

Thomas Lempert, Tom Bschor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21274696     DOI： 10.1007/s00115-010-3233-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  4 in total

1.  [The concept of the development of S3 guidelines: additional benefit compared to traditional standards, problems and solutions].

Authors:  A Pfennig; I Kopp; D Strech; M Bauer
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

2.  [Guideline intentions of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN)].

Authors:  T Wobrock; F Schneider; P Falkai
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

Review 3.  [Critical observations on measuring quality of life of persons suffering from dementia].

Authors:  H-J Gertz; M Berwig
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

4.  Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.

Authors:  Matthias W Riepe; Thomas Mittendorf; Hans Förstl; Lutz Frölich; Martin Haupt; Reiner Leidl; Christoph Vauth; Matthias Graf von der Schulenburg
Journal:  BMC Neurol       Date:  2009-08-25       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.